COMPANY

NeuralInk

Profile checked Oct 10, 2026

Keywords: Tetraplegia/Tetraparesis Quadriplegia Cervical Spinal Cord Injury Quadriplegia/Tetraplegia Amyotrophic Lateral Sclerosis Spinal Cord Injury (Quadraplegia) Spinal Cord Injury Motor Neuron Disease Brain Stem Stroke Stroke Spinal Cord Injury Cervical

$650.0MRaised (2 yrs)6Trials (company is sponsor)

Timeline

Oct 3, 2025 Trial start Not phased (device or behavioral study): VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration source ↗
Jul 31, 2025 Trial start Not phased (device or behavioral study): GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices source ↗
Jun 2, 2025 Raise Private equity round — Series E: $650M (total, as published), announced Jun 2, 2025. Source: company's own press page. source ↗
May 9, 2025 Trial start Not phased (device or behavioral study): UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices source ↗
Nov 25, 2024 Trial start Not phased (device or behavioral study): Control of Assistive Devices Via Brain-Computer Interface Technology source ↗
Nov 20, 2024 Trial start Not phased (device or behavioral study): CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices source ↗
Jan 9, 2024 Trial start Not phased (device or behavioral study): Precise Robotically IMplanted Brain-Computer InterfacE source ↗

Upcoming milestones

2026-11 (ESTIMATED) · Not phased · UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices · NCT06992596
Nov 30, 2027 (ESTIMATED) · Not phased · CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices · NCT06700304
2028-01 (ESTIMATED) · Not phased · GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices · NCT07127172
2028-10 (ESTIMATED) · Not phased · VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration · NCT07224256
May 25, 2031 (ESTIMATED) · Not phased · Control of Assistive Devices Via Brain-Computer Interface Technology · NCT06710626

Estimated primary completion per ClinicalTrials.gov. Dates move.

Funding

Raised: $650.0M. Last 2 years.

Jun 2, 2025 Private equity round — Series E: $650M (total, as published), announced Jun 2, 2025. Source: company's own press page. source ↗

Clinical trials (lead sponsor) 6

Record	Title	Phase	Status	Start	Primary completion
NCT06429735	Precise Robotically IMplanted Brain-Computer InterfacE	Not phased (device or behavioral study)	Recruiting	Jan 9, 2024	2026-06 (estimated)
NCT07224256	VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration	Not phased (device or behavioral study)	Recruiting	Oct 3, 2025	2028-10 (estimated)
NCT07127172	GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices	Not phased (device or behavioral study)	Recruiting	Jul 31, 2025	2028-01 (estimated)
NCT06992596	UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices	Not phased (device or behavioral study)	Recruiting	May 9, 2025	2026-11 (estimated)
NCT06710626	Control of Assistive Devices Via Brain-Computer Interface Technology	Not phased (device or behavioral study)	Enrolling by invitation	Nov 25, 2024	May 25, 2031 (estimated)
NCT06700304	CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices	Not phased (device or behavioral study)	Recruiting	Nov 20, 2024	Nov 30, 2027 (estimated)